glp 1 agonist kidney disease GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute Discoveries in Medicine - GLP-1

The FDA label lists Type 2 diabetes and cardiovascular risk reduction in adults with Type 2 diabetes and established cardiovascular disease as approved uses

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

Glutathione-associated cis -diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells

Science 334 , 105108 (2011)

Alongside its effects on GLP-1, it also mimics the actions of another hormone called GIP (gastric inhibitory polypeptide) that reduces blood sugar levels

$52 Our products are provided in a freeze-dried, lyophilized powder that is vacuum sealed in a sterile vial format that typically require reconstitution with an applicable solvent or solution and intended for research use only